Clinical Trial Update: Dietary Bioflavonoid Supplementation for the Prevention of Neoplasia Recurrence [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial investigating dietary bioflavonoid supplementation to prevent recurrence of neoplasia in colorectal cancer has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Dietary bioflavonoid supplement

Snippet

Sponsor: Technische Universität Dresden | Conditions: Colorectal Cancer | Phase 2 | Status: SUSPENDED